All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Maintaining Weight Loss After Ozempic: Tips And Tricks

Dr. Eric Berg DC

158K views on YouTubeWatch on YouTube

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Stopping GLP-1 DrugsCompounded SemaglutideProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Compounded Semaglutide access requires the right clinical path

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For Maintaining Weight Loss After Ozempic: Tips And Tricks, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Video claim decision path

Turn the claim into a safer next question

Direct answer

Compounded Semaglutide should be treated as a claim to verify, then compared with evidence, safety context, and a provider review path.

Evidence check

Social clips are useful prompts, but they rarely show the full evidence base, contraindications, or dosing context.

Safety check

A viral claim can miss patient-specific risks, medication interactions, legal access, and source quality.

Next step

If the claim matches your goal, use the get-started flow to move from curiosity into a supervised prescription review.

Claim path

Keep researching this semaglutide video claims cluster

Best for searchers comparing social semaglutide claims with GLP-1 eligibility, outcomes, and safety context.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "Maintaining Weight Loss After Ozempic: Tips And Tricks" from Dr. Eric Berg DC. We read the clip as a Stopping GLP-1 Drugs claim about Compounded Semaglutide, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: Use the appetite-suppression window from Ozempic to address underlying metabolic issues like insulin resistance rather than just eating less of the same foods

The reason this review is not generic is the source wording and the canonical claim label "glp1 stopping maintaining weight loss after ozempic tips and tricks." In this clip, the useful excerpt is: "Use the appetite-suppression window from Ozempic to address underlying metabolic issues like insulin resistance rather than just eating less of the same foods" That wording changes the review because it points to Compounded Semaglutide safety, access, evidence, and fit, not a one-size-fits-all protocol.

The source trail for this page is checked against Once-Weekly Semaglutide in Adults with Overweight or Obesity (2021), Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance (2021), and Effect of Weekly Subcutaneous Semaglutide vs Daily Liraglutide on Body Weight (2022), plus the creator's own wording. Compounded Semaglutide still needs an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Transitioning to a lower-carb, nutrient-dense diet during GLP-1 treatment gives you the best chance of maintaining results after stopping
People who land here are usually comparing the Compounded Semaglutide claim with glp1 and stopping.
The strongest next step is to compare the claim with FormBlends' Compounded Semaglutide guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

Use the appetite-suppression window from Ozempic to address underlying metabolic issues like insulin resistance rather than just eating less of the same foods

FormBlends verdict

Compounded Semaglutide safety, access, evidence, and fit

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with the Compounded Semaglutide guide, safety notes, access rules, and a licensed-provider review.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The video is useful as a prompt for better questions, but it should not be treated as a personalized treatment plan.
  • Use the appetite-suppression window from Ozempic to address underlying metabolic issues like insulin resistance rather than just eating less of the same foods
  • Transitioning to a lower-carb, nutrient-dense diet during GLP-1 treatment gives you the best chance of maintaining results after stopping

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compounded Semaglutide decisions still need source quality, legal access, and provider oversight checks.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against the Compounded Semaglutide guide, cost path, safety notes, and provider review before acting.

Review Compounded Semaglutide

What You'll Learn

  • Use the appetite-suppression window from Ozempic to address underlying metabolic issues like insulin resistance rather than just eating less of the same foods
  • Transitioning to a lower-carb, nutrient-dense diet during GLP-1 treatment gives you the best chance of maintaining results after stopping
  • Gradual progression with intermittent fasting (three meals to two meals to potentially one meal a day) can help maintain lower insulin levels post-medication
  • Sleep quality and stress management directly affect insulin resistance and appetite hormones, making them non-optional parts of a maintenance plan
  • Nutritional deficiencies can develop during GLP-1 use due to reduced food intake, so prioritizing nutrient-dense foods is especially important

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

Dr. Berg's Playbook for Life After Ozempic

Dr. Eric Berg tackles one of the most searched-for topics in the GLP-1 space: what happens after you stop taking the medication, and how do you keep the weight off? With 158K views, this video clearly resonates with the large and growing population of people who have lost weight on Ozempic and are now wondering about their next chapter. Berg's approach leans heavily on dietary strategies and metabolic principles, which is consistent with his broader content philosophy.

Berg starts by acknowledging what the research shows: weight regain after stopping GLP-1 medications is the norm, not the exception. Studies have found that people regain roughly two-thirds of their lost weight within a year of stopping. He does not try to minimize this reality, but he does argue that the regain is not inevitable if you make specific, sustainable changes during your time on the medication.

His central thesis is that Ozempic gives you a window of reduced appetite that you should use strategically to fix the underlying metabolic issues that drove weight gain in the first place. If you spend your time on the medication simply eating less of the same foods, you have not changed the metabolic dynamics, and regain becomes almost guaranteed when the appetite suppression goes away. But if you use that window to transition to a way of eating that addresses insulin resistance and metabolic health, you have a much better shot at maintaining your results.

The Dietary Framework Berg Recommends

Berg's recommended approach centers on reducing insulin levels through a combination of lower carbohydrate intake and intermittent fasting. His argument is that chronically elevated insulin is the primary driver of fat storage and that lowering insulin through dietary changes can reset your body's weight regulation even after you stop taking Ozempic. He recommends transitioning to a diet rich in non-starchy vegetables, moderate protein, and healthy fats while gradually reducing processed carbohydrates, sugars, and refined starches.

The intermittent fasting component involves gradually extending the time between meals. Berg suggests starting with three meals a day without snacking, then progressing to two meals within an eight-hour window, and eventually experimenting with one meal a day (OMAD) if it feels sustainable. His reasoning is that each hour spent in a fasted state is time your body spends with lower insulin levels, which promotes fat burning and metabolic flexibility.

He also emphasizes the importance of nutrient density. One of the side effects of Ozempic is reduced food intake, which can lead to nutritional deficiencies if the food you do eat is not nutrient-rich. Berg recommends prioritizing foods high in B vitamins, magnesium, potassium, and essential fatty acids. He specifically mentions eggs, liver, fatty fish, leafy greens, and fermented foods as nutrient-dense options that support metabolic health during and after GLP-1 use.

Beyond Diet: The Supporting Cast

While diet is the main focus, Berg does touch on other factors that support weight maintenance after Ozempic. Sleep quality gets a mention, with Berg noting that poor sleep increases insulin resistance and appetite-stimulating hormones like ghrelin. He recommends seven to nine hours of quality sleep and suggests addressing sleep issues before attempting to stop the medication.

Stress management also comes up. Chronic stress elevates cortisol, which promotes visceral fat storage and insulin resistance. Berg suggests finding sustainable stress-reduction practices, whether that is walking, meditation, breathing exercises, or whatever works for the individual. The point is not which specific practice you choose, but that you have something in place.

Exercise gets less attention than you might expect. Berg mentions walking as a daily baseline and suggests some resistance training for muscle preservation, but he does not build out a detailed exercise protocol the way some other practitioners do. His view seems to be that dietary changes do the heavy lifting for weight maintenance, with exercise playing a supporting but secondary role.

What the Video Gets Right and Where It Falls Short

Berg's emphasis on using the Ozempic window to make sustainable dietary changes is smart advice. Too many people treat GLP-1 medications as a standalone solution rather than a catalyst for deeper habit change. His point about addressing insulin resistance specifically, rather than just reducing calories, reflects real metabolic science even if his specific dietary recommendations lean more prescriptive than the evidence strictly supports.

Where the video falls short is in oversimplifying the metabolic picture. Insulin resistance is a real and important factor in weight regulation, but it is not the only one. Leptin resistance, changes in gut microbiome composition, adaptive thermogenesis, and neurological reward pathways all play roles in post-medication weight regain. Framing the solution primarily around insulin reduction misses some of these factors. The video would be stronger with a more complete picture of post-GLP-1 metabolic dynamics.

The intermittent fasting recommendations also deserve a caveat. While intermittent fasting works well for some people, it can be counterproductive for others, particularly those with a history of disordered eating, women dealing with hormonal fluctuations, or people on certain medications. Berg's one-size-fits-all presentation of fasting does not account for these individual differences.

Berg's point about using the appetite-suppression window strategically is one of the most actionable pieces of advice in the post-GLP-1 content space. Many patients treat their time on Ozempic as a passive experience: the drug suppresses appetite, they eat less, they lose weight. But Berg argues that this passivity is a wasted opportunity. The reduced appetite is a window during which building new food habits is dramatically easier than it would be without pharmacological support. Learning to cook nutrient-dense meals, developing a taste for vegetables and whole foods, breaking snacking patterns, and establishing regular meal timing are all easier when your brain is not screaming at you to eat constantly. If you invest this effort during treatment, you have a portfolio of established habits to draw on when the medication is discontinued.

The nutrient density angle is particularly relevant for GLP-1 users because reduced food intake creates a higher bar for the quality of what you do eat. If you are eating 1,500 calories a day instead of 2,500, every calorie matters more for meeting your nutritional needs. Eating 1,500 calories of processed convenience food will leave you deficient in multiple vitamins and minerals within weeks, while the same caloric amount from nutrient-dense whole foods can meet most of your micronutrient requirements. Berg's emphasis on eggs, liver, fatty fish, and leafy greens is well-founded from a nutrient-density perspective, though his specific food recommendations are more prescriptive than they need to be. The general principle is sound: on a reduced calorie budget, you cannot afford nutritional empty calories.

The intermittent fasting component of Berg's recommendations is where individual variation matters most. Some people thrive on time-restricted eating, finding that it simplifies their day and reduces decision fatigue around food. Others find it increases anxiety, triggers binge eating behaviors, or disrupts their social and family eating patterns. Women, in particular, may respond differently to extended fasting due to hormonal considerations, with some research suggesting that aggressive fasting protocols can disrupt menstrual cycles and increase cortisol. Berg's one-size-fits-all presentation does not account for this variability, so viewers should treat his fasting recommendations as one option to experiment with rather than a universal prescription.

One area where this video could add value is in discussing the role of community and social support in post-Ozempic maintenance. Weight management does not happen in isolation, and the people around you have an enormous influence on your food environment, activity patterns, and emotional state. Finding a community of people who have gone through similar GLP-1 experiences, whether online or in person, provides both practical tips and emotional support during the vulnerable post-medication period. Knowing that other people are navigating the same challenges and that your experience is normal rather than a personal failure can make a meaningful difference in your ability to maintain momentum through the difficult early weeks and months after stopping.

Questions to Discuss With Your Provider

Before implementing any post-Ozempic strategy, talk to your prescriber. Ask whether your current metabolic markers (fasting insulin, HOMA-IR, A1C, lipids) suggest that your underlying insulin resistance has improved during treatment. Ask about a taper schedule rather than abrupt discontinuation. Ask whether an intermittent fasting approach is appropriate given your specific health history. Ask about nutritional testing to identify any deficiencies that developed during the reduced-appetite phase. And ask about a monitoring schedule to catch early weight regain before it becomes a larger problem.

Who Should Watch This

This video is most useful for people who are currently on Ozempic and want to start planning for what comes after. Berg's dietary framework gives you something concrete to work toward during your time on the medication. It is also relevant for people who have already stopped and are experiencing regain and want a structured approach to address it. If you are someone who responds well to low-carb and fasting approaches, this will feel actionable. If you have tried those approaches and they did not work for you, you may want to look for content that offers a broader range of dietary strategies for post-GLP-1 maintenance.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Dr. Eric Berg DC ·

158K views on this video

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about use the appetite-suppression window from ozempic to address underlying metabolic?

Use the appetite-suppression window from Ozempic to address underlying metabolic issues like insulin resistance rather than just eating less of the same foods

What does the video say about transitioning to a lower-carb, nutrient-dense diet during glp-1 treatment gives?

Transitioning to a lower-carb, nutrient-dense diet during GLP-1 treatment gives you the best chance of maintaining results after stopping

What does the video say about gradual progression with intermittent fasting (three meals to two meals?

Gradual progression with intermittent fasting (three meals to two meals to potentially one meal a day) can help maintain lower insulin levels post-medication

What does the video say about sleep quality?

Sleep quality and stress management directly affect insulin resistance and appetite hormones, making them non-optional parts of a maintenance plan

What does the video say about nutritional deficiencies can develop during glp-1 use due to reduced?

Nutritional deficiencies can develop during GLP-1 use due to reduced food intake, so prioritizing nutrient-dense foods is especially important

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Dr. Eric Berg DC, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.